The Traderszone Network

19 October, 2016 by The TZ Newswire Staff Comments Off on EURUSD orders 20 Oct

EURUSD orders 20 Oct

Currently 1.0975 tightly pinned between 1.0950-80 so far as we wait on ECB
in play.
Large option expiries
Offers:  1.1085 1.1130
1.0980
1.1000
Bids:   

19 October, 2016 by The TZ Newswire Staff Comments Off on EURGBP orders 20 Oct

EURGBP orders 20 Oct

Currently 0.8937 having held 0.8920 again in early selling
ECB and UK retail sales the scheduled risk events
Offers:  0.8955   
0.8975-80 0.9000 
Bids:    0.8920

19 October, 2016 by The TZ Newswire Staff Comments Off on GBPUSD orders 20 Oct

GBPUSD orders 20 Oct

Currently 1.2274 in a general range of 1.2240-1.2340 for the moment
Order board still reflecting key areas in that range and therefore largely unchanged-reinstated

19 October, 2016 by The TZ Newswire Staff Comments Off on Matthew Lynn’s London Eye: Mr. Market won’t be able to stop and reverse Brexit

Matthew Lynn’s London Eye: Mr. Market won’t be able to stop and reverse Brexit

Markets are punishing British assets, leading some people to suggest that the markets could force Britain to back out of Brexit, but Matthew Lynn explains why that’s not going to happen.
read more

19 October, 2016 by The TZ Newswire Staff Comments Off on Futures Movers: Oil prices pull back as investors cash in on gains spurred by inventory drop

Futures Movers: Oil prices pull back as investors cash in on gains spurred by inventory drop

Oil prices shot up to more than a one-year high overnight after Energy Information Administration data showed U.S.

read more

19 October, 2016 by The TZ Newswire Staff Comments Off on Rebound In Eurozone Employment: The Main Contributors

Rebound In Eurozone Employment: The Main Contributors

19 October, 2016 by The TZ Newswire Staff Comments Off on ABLYNX OUTLINES NEXT STEPS FOR ITS ANTI-IL-6R NANOBODY, VOBARILIZUMAB, A POTENTIAL BEST-IN-CLASS TREATMENT FOR RHEUMATOID ARTHRITIS

ABLYNX OUTLINES NEXT STEPS FOR ITS ANTI-IL-6R NANOBODY, VOBARILIZUMAB, A POTENTIAL BEST-IN-CLASS TREATMENT FOR RHEUMATOID ARTHRITIS